Skip to content
★ Sign in to follow
MN

Mats Nilsson Bernitz

QuiaPEG Pharmaceuticals Holding AB
Total declarations
9
Company
1
▲ Purchases (2 ops.)
€49k
▼ Sales (0 ops.)
—

Latest filing published 29 May 2022 for QuiaPEG Pharmaceuticals Holding AB, €39k.

Filing timeline

BuySale
Mats Nilsson Bernitz

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Mats Nilsson Bernitz: trading record in brief

All filings by Mats Nilsson Bernitz on record concern QuiaPEG Pharmaceuticals Holding AB. The record holds 9 filings, for trades running from 3 July 2020 to 27 May 2022.

Purchases make up the whole of the open-market record (2 purchases, €49k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2022, the count stands at 1 purchase and no sales.

The record was last updated on 29 May 2022 with an open-market purchase (€39k) in QuiaPEG Pharmaceuticals Holding AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Mats Nilsson Bernitz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations